Market Cap ₹33 Cr.
Stock P/E
P/B 1.5
Current Price ₹21.7
Book Value ₹ 14.7
Face Value 10
52W High ₹30.6
Dividend Yield 0%
52W Low ₹ 12.3
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) |
---|
Net Sales |
Other Income |
Total Income |
Total Expenditure |
Operating Profit |
Interest |
Depreciation |
Exceptional Income / Expenses |
Profit Before Tax |
Provision for Tax |
Profit After Tax |
Adjustments |
Profit After Adjustments |
Adjusted Earnings Per Share |
#(Fig in Cr.) | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|
Net Sales | 30 | 64 | 74 | 72 | 95 | |
Other Income | 0 | 0 | 0 | 0 | 0 | |
Total Income | 30 | 64 | 74 | 72 | 95 | |
Total Expenditure | 28 | 60 | 69 | 67 | 90 | |
Operating Profit | 3 | 4 | 5 | 5 | 5 | |
Interest | 1 | 2 | 2 | 3 | 3 | |
Depreciation | 0 | 1 | 1 | 1 | 1 | |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | |
Profit Before Tax | 1 | 1 | 2 | 2 | 2 | |
Provision for Tax | 0 | 0 | 0 | 0 | 0 | |
Profit After Tax | 1 | 1 | 1 | 2 | 2 | |
Adjustments | 0 | 0 | 0 | 0 | 0 | |
Profit After Adjustments | 1 | 1 | 1 | 2 | 2 | |
Adjusted Earnings Per Share | 0.7 | 0.8 | 1.3 | 1.5 | 1.2 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 32% | 14% | 0% | 0% |
Operating Profit CAGR | 0% | 8% | 0% | 0% |
PAT CAGR | 0% | 26% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 59% | NA% | NA% | NA% |
ROE Average | 10% | 10% | 9% | 9% |
ROCE Average | 11% | 11% | 10% | 10% |
#(Fig in Cr.) | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|
Shareholder's Funds | 12 | 13 | 14 | 15 | 22 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 |
Borrowings | 3 | 4 | 7 | 8 | 9 |
Other Non-Current Liabilities | 0 | 0 | 1 | 1 | 1 |
Total Current Liabilities | 20 | 23 | 30 | 28 | 23 |
Total Liabilities | 35 | 41 | 52 | 51 | 54 |
Fixed Assets | 9 | 8 | 9 | 10 | 13 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Total Current Assets | 26 | 32 | 43 | 42 | 40 |
Total Assets | 35 | 41 | 52 | 51 | 54 |
#(Fig in Cr.) | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 0 | 0 | 0 | 0 | 0 |
Cash Flow from Operating Activities | -1 | -4 | -0 | 3 | 1 |
Cash Flow from Investing Activities | -2 | -0 | -1 | -2 | -4 |
Cash Flow from Financing Activities | 2 | 4 | 2 | -1 | 3 |
Net Cash Inflow / Outflow | 0 | -0 | 0 | -0 | 0 |
Closing Cash & Cash Equivalent | 0 | 0 | 0 | 0 | 0 |
# | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|
Earnings Per Share (Rs) | 0.67 | 0.82 | 1.27 | 1.45 | 1.21 |
CEPS(Rs) | 1.05 | 1.35 | 1.84 | 2.09 | 1.77 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 10.62 | 11.44 | 12.71 | 13.93 | 14.35 |
Core EBITDA Margin(%) | 7.08 | 5.65 | 6.02 | 6.75 | 5.67 |
EBIT Margin(%) | 5.97 | 4.82 | 5.26 | 5.8 | 4.8 |
Pre Tax Margin(%) | 2.91 | 1.91 | 2.56 | 2.34 | 2.13 |
PAT Margin (%) | 2.05 | 1.41 | 1.89 | 2.21 | 1.92 |
Cash Profit Margin (%) | 3.21 | 2.33 | 2.74 | 3.17 | 2.8 |
ROA(%) | 2.11 | 2.36 | 3.02 | 3.1 | 3.47 |
ROE(%) | 6.34 | 7.4 | 10.53 | 10.9 | 9.88 |
ROCE(%) | 8.44 | 10.5 | 11 | 10.8 | 10.5 |
Receivable days | 125.1 | 72.17 | 76.73 | 80.42 | 60.6 |
Inventory Days | 127.01 | 86.81 | 98.12 | 121.78 | 87.83 |
Payable days | 129.06 | 48.61 | 39.77 | 47.84 | 26.99 |
PER(x) | 0 | 0 | 0 | 0 | 11.93 |
Price/Book(x) | 0 | 0 | 0 | 0 | 1.01 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 0.82 | 0.49 | 0.47 | 0.49 | 0.49 |
EV/Core EBITDA(x) | 9.63 | 8.53 | 7.67 | 7.23 | 8.69 |
Net Sales Growth(%) | 0 | 110.44 | 16.28 | -2.11 | 31.67 |
EBIT Growth(%) | 0 | 41.99 | 26.93 | 8.01 | 8.95 |
PAT Growth(%) | 0 | 21.11 | 55.72 | 14.18 | 14.3 |
EPS Growth(%) | 0 | 21.11 | 55.72 | 14.18 | -16.57 |
Debt/Equity(x) | 1.19 | 1.6 | 1.71 | 1.6 | 1.18 |
Current Ratio(x) | 1.29 | 1.38 | 1.43 | 1.49 | 1.77 |
Quick Ratio(x) | 0.67 | 0.63 | 0.69 | 0.55 | 0.91 |
Interest Cover(x) | 1.95 | 1.66 | 1.95 | 1.68 | 1.8 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 1.17 |
# | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 |
---|---|---|---|---|
Promoter | 38.87 | 38.87 | 38.87 | 38.87 |
FII | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 |
Public | 61.13 | 61.13 | 61.13 | 61.13 |
Others | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 |
# | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 |
---|---|---|---|---|
Promoter | 0.59 | 0.59 | 0.59 | 0.59 |
FII | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 |
Public | 0.92 | 0.92 | 0.92 | 0.92 |
Others | 0 | 0 | 0 | 0 |
Total | 1.51 | 1.51 | 1.51 | 1.51 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About